By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

DiagnoCure Inc. 

2050 Boulevard, Rene-Levesque Ouest, 6th Floor

Sainte-Foy  Quebec  G1V 2K8  Canada
Phone: 418-527-6100 Fax: 418-527-0240


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals

Collaborations

Gen-Probe Incorporated (Acquired by Hologic)  In November 2003, Gen-Probe signed a license and collaboration agreement with DiagnoCure under which the companies are developing, and Gen-Probe will market, an innovative urine test to detect a new, highly specific genetic marker for prostate cancer called PCA3.





Company News
Shuwen Biotech And DiagnoCure (CUR) Sign Exclusive License And Collaboration Agreement For Commercializing Previstage™ GCC Colorectal Cancer Staging Test In China 6/6/2014 10:51:37 AM
DiagnoCure (CUR) Announces Second Quarter 2014 Results 6/5/2014 7:13:38 AM
DiagnoCure (CUR) Announces Results Of Its Annual General And Special Meeting Of Shareholders 4/18/2014 6:17:22 AM
DiagnoCure (CUR) Announces First Quarter 2014 Results 3/17/2014 8:14:39 AM
DiagnoCure (CUR) Announces Fourth Quarter 2013 And Year-End Results 1/17/2014 6:19:02 AM
DiagnoCure (CUR) Announces Resignation of CFO 10/1/2013 6:15:54 AM
DiagnoCure (CUR) Grants Stock Options to Senior Advisor 9/18/2013 8:26:02 AM
DiagnoCure (CUR) Announces Third Quarter 2013 Results 9/5/2013 6:58:51 AM
DiagnoCure (CUR) to Host Q3 2013 Earnings Conference Call and Webcast 8/27/2013 6:21:07 AM
DiagnoCure (CUR) Appoints Richard Bordeleau as Senior Advisor to the Board 8/20/2013 6:10:51 AM
12345678910...
//-->